EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Randomisierte kontrollierte Studie

Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer

Hiroomi Ogawa, Takuya Shiraishi, Takuhisa Okada, Yohei Miyamae, Yoko Motegi, Ken Shirabe, Hiroshi Saeki

Anticancer Research · 2024

DOI: 10.21873/anticanres.16872 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Anticancer Research, 2024. Verfasst von Hiroomi Ogawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterological Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan; hiroo…. Hauptthemen laut MEDLINE: Chemotherapy, Adjuvant, Colorectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemotherapy, AdjuvantColorectal NeoplasmsHumansAdministration, OralLeucovorinLevamisoleNeoplasm StagingTegafurUracil

Stichwörter der Autor:innen

Polysaccharide Kadjuvant chemotherapycolorectal cancerpostoperative therapy

Substanzen

LeucovorinLevamisoleTegafurUracil

Autor:innen und Institutionen

  • Division of Gastroenterological Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan; hiroomio@gunma-u.ac.jp.
  • Division of Gastroenterological Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Department of Surgery, Takasaki General Medical Center, Takasaki, Japan.
  • General Surgery, Japan Red Cross Maebashi Hospital, Maebashi, Japan.
  • Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.

Zitieren

APA

Ogawa, H., Shiraishi, T., Okada, T., Miyamae, Y., Motegi, Y., Shirabe, K., & Saeki, H. (2024). Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.16872

Vancouver

Ogawa H, Shiraishi T, Okada T, Miyamae Y, Motegi Y, Shirabe K, et al. Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.16872

BibTeX
@article{Ogawa2024,
  author = {Ogawa, Hiroomi and Shiraishi, Takuya and Okada, Takuhisa and Miyamae, Yohei and Motegi, Yoko and Shirabe, Ken and Saeki, Hiroshi},
  title = {Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.16872}
}
Kostenlos starten →